HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.

Abstract
Hepatoma-derived growth factor (HDGF) is frequently overexpressed in human cancer. The growth factor was previously demonstrated to be a survival factor as knock-down of HDGF suppresses the growth and induces apoptosis in human cancer cells through the Bad-mediated intrinsic apoptotic pathway. However, inactivation of Bad cannot completely repress the apoptosis induced upon HDGF knock-down, indicating the presence of other unidentified pathways. In the present study, HDGF knock-down was shown to trigger the Fas-mediated extrinsic apoptotic pathway in human hepatocellular carcinoma HepG2 cells through NF-kappaB signaling pathway. Increases in Fas expression and fas promoter activity were detected upon HDGF knock-down by Western blot analysis and luciferase reporter assay. Knock-down of fas inhibited HDGF knock-down effect on apoptosis induction and growth suppression as revealed by annexin V binding assay and soft agar assay. Down-regulation of IkappaBalpha was also observed upon HDGF knock-down. Overexpression of IkappaBalpha by transient transfection or inhibition of NF-kappaB by BAY11-7082 suppressed HDGF knock-down effect on fas promoter activation, Fas up-regulation, apoptosis induction and growth suppression. Furthermore, the interaction of Fas-mediated extrinsic and Bad-mediated intrinsic apoptotic pathways was demonstrated as a stronger inhibition on apoptosis induction and growth suppression upon HDGF knock-down was observed when both pathways were inactivated. The results therefore suggested that, through both intrinsic and extrinsic apoptotic pathways, HDGF may function as a survival factor and be a potential target for cancer therapy.
AuthorsTsun Yee Tsang, Wan Yee Tang, Wing Pui Tsang, Ngai Na Co, Siu Kai Kong, Tim Tak Kwok
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 24 Issue 3-4 Pg. 253-62 ( 2009) ISSN: 1421-9778 [Electronic] Germany
PMID19710540 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2009 S. Karger AG, Basel.
Chemical References
  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Annexin A5
  • Intercellular Signaling Peptides and Proteins
  • NF-kappa B
  • Nitriles
  • Oligonucleotides, Antisense
  • RNA, Small Interfering
  • Sulfones
  • bcl-Associated Death Protein
  • fas Receptor
  • hepatoma-derived growth factor
  • Luciferases, Renilla
Topics
  • Annexin A5 (analysis, metabolism)
  • Apoptosis
  • Carcinoma, Hepatocellular (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • DNA Fragmentation (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Genes, Reporter
  • Humans
  • Intercellular Signaling Peptides and Proteins (genetics)
  • Liver Neoplasms (genetics, metabolism, pathology)
  • Luciferases, Renilla (metabolism)
  • Models, Biological
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Nitriles (pharmacology)
  • Oligonucleotides, Antisense (pharmacology)
  • RNA, Small Interfering (metabolism)
  • Signal Transduction
  • Sulfones (pharmacology)
  • Transfection
  • bcl-Associated Death Protein (metabolism)
  • fas Receptor (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: